February 5th, 2016 – Philadelphia, PA Longevity Biotech featured in Philadelphia Business Journal
Read More
Vasoactive intestinal peptide (VIP) mediates a broad range of biological responses by activating two related receptors, VIP receptor 1 and 2 (VIPR1 and VIPR2). Although the use of native VIP…
Read More
December 16th, 2015 – Philadelphia, PA Neuroinflammation Research published in Journal of Neuroscience Press Release
Read More
Updated: DEC 16, 2015 Allows immune system to repair brain damage; results reported in Journal of Neuroscience Philadelphia, PA, December 16, 2015 (Newswire.com) - A team of scientists at the University of…
Read More
SBIR Phase II: Novel approach to the oral delivery of biologically active peptide analogs. Click here for more details on this NSF Phase II Grant.
Read More
June 15-18th, 2015 – Philadelphia, PA PRESENTATION Tuesday June 16th @ 3:15pm. Theater 3, “Doctor Nucleus” Longevity Biotech will be participating at this year’s international BIO conference. Please contact us…
Read More
May 1st, 2015 Longevity Biotech awarded funds from Micheal J. Fox Foundation to determine key mechanisms and safety of a Parkinson’s disease therapeutic drug candidate.
Read More
April 15th, 2015 Longevity Biotech awarded NSF Phase II grant to further oral peptide delivery efforts.
Read More
March 1st, 2015 Longevity applies innovative platform to CNS biologics.
Read More
November 20th, 2014 – NY, NY EpiBone, Longevity Biotech and Modern Meadow to headline Breakout Labs event in NY, NY
Read More